From Financial Modeling Prep: 2024-12-16 16:00:04

Clearside Biomedical, Inc. (NASDAQ:CLSD) is a biopharmaceutical company specializing in eye disease treatments. With a ROIC of 56.84%, Clearside outperforms competitors like Cidara Therapeutics, Leap Therapeutics, and Selecta Biosciences. The company’s 3.19 ROIC to WACC ratio demonstrates efficient capital utilization, making it an appealing investment option for stakeholders.



Read more at Financial Modeling Prep:: Clearside Biomedical, Inc. (NASDAQ:CLSD) Outperfor…